Camilleri, Michael
Chedid, Victor
Ford, Alexander C.
Haruma, Ken
Horowitz, Michael
Jones, Karen L.
Low, Phillip A.
Park, Seon-Young
Parkman, Henry P.
Stanghellini, Vincenzo
Article History
First Online: 1 November 2018
Competing interests
: M.C. consults with Allergan on relamorelin (consulting fee to his employer, Mayo Clinic) and consults with Shire on prucalopride (consulting fee to his employer, Mayo Clinic) and has received a research grant from Takeda for study on TAK-954. All other authors declare no noteworthy conflicts of interest.